Martinelli G, Buzzi M, Farabegoli P, Testoni N, Mantovani V, Calori E, Rosti G, Bandini G, Bragliani M, Panzica G
Institute of Hematology L. e A. Seragnoli, University of Bologna, Italy.
Bone Marrow Transplant. 1993;11 Suppl 1:31-2.
An important problem in the selection of unrelated donors for bone marrow transplantation (UD-BMT), is HLA matching, between selected donor and recipient. Serological screening, mixed lymphocyte culture (MLC), and sequence specific oligonucleotide genotyping (PCR-SSO) are the methods commonly used for typing of HLA-genes. These ways to select donor candidates are time-expensive. We set up new applications of the "fingerprinting-PCR" technique, to analyse the polymorphic second exon of DRB, DQB, DQA, DPB of HLA Class II and second exon A, B, C HLA-Class I genes, and to search for identity between patient and serologically selected unrelated donors. In an assessment of the technique, 50 normal samples, and 4 unrelated HLA-A and HLA-B serological matched patient-donor pairs were analysed for HLA polymorphic regions. In 3 of the 4 cases (UD-BMT) at least HLA-DRB mismatched different donor-transplanted patterns were identified. In all cases PCR-SSO analysis was performed as control. Based on our data, we suggest that identification of UD for allogeneic BMT should follow these steps: 1) serological HLA-Class I and II genes screening; 2) HLA-Class II DRB gene PCR fingerprinting; 3) confirmation by SSO analysis in case of fingerprinting identity. 4) HLA-Class II DQA, DQB, DPB PCR fingerprinting. Moreover, confirmation by PCR fingerprinting or protein isoelectrofocusing of HLA-Class I identity is recommended. This "strategy" may contribute to rapid and specific selection of unrelated marrow donors.
骨髓移植(UD - BMT)中选择无关供体的一个重要问题是所选供体与受体之间的HLA匹配。血清学筛查、混合淋巴细胞培养(MLC)和序列特异性寡核苷酸基因分型(PCR - SSO)是常用于HLA基因分型的方法。这些选择供体候选者的方法既耗时又昂贵。我们建立了“指纹PCR”技术的新应用,以分析HLA - II类的DRB、DQB、DQA、DPB的多态性第二外显子以及HLA - I类的第二外显子A、B、C,并寻找患者与血清学选择的无关供体之间的一致性。在对该技术的评估中,对50个正常样本以及4对HLA - A和HLA - B血清学匹配的患者 - 供体对进行了HLA多态性区域分析。在4例(UD - BMT)中的3例中,至少鉴定出了HLA - DRB不匹配的不同供体移植模式。在所有病例中均进行了PCR - SSO分析作为对照。基于我们的数据,我们建议同种异体BMT的无关供体鉴定应遵循以下步骤:1)血清学HLA - I类和II类基因筛查;2)HLA - II类DRB基因PCR指纹分析;3)指纹分析一致时通过SSO分析进行确认。4)HLA - II类DQA、DQB、DPB PCR指纹分析。此外,建议通过PCR指纹分析或HLA - I类一致性的蛋白质等电聚焦进行确认。这种“策略”可能有助于快速、特异性地选择无关骨髓供体。